Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association Study

Jonat, W.; Kaufmann, M.; Sauerbrei, Willi; Blamey, R.W.; Cuzick, J.; Namer, M.; Fogelman, I.; C de Haes, J; De Matteis, A.; L. Stewart, Alan; Eiermann, W.; Szakolczai, I; K Palmer, M; Schumacher, Martin; Geberth, Matthias; Lisboa, B.

doi:10.1200/jco.2002.05.042

Public

Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy in Premenopausal Patients With Node-Positive Breast Cancer: The Zoladex Early Breast Cancer Research Association Study

Published in Journal of Clinical Oncology • Dec 15, 2002

Authors:

W. Jonat

M. Kaufmann

Willi Sauerbrei

Abstract

PURPOSE: Current adjuvant therapies have improved survival for premenopausal patients with breast cancer but may have short-term toxic effects and long-term effects associated with premature menopause. PATIENTS AND METHODS: The Zoladex Early Breast Cancer Research Association study assessed the effi...

Subject

Goserelin

Medicine

Breast cancer

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!